The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Goodwin

100 NORTHERN AVENUE, BOSTON MA 02210, USA
Tel:
Work +617 570 1000
Fax:
Fax +617 523 1231
Email:
Web:
www.goodwinlaw.com

Kingsley Taft

Tel:
Work +1 617 570 1222
Email:
Goodwin

Position

Partner

Career

Kingsley Taft is a senior partner and national co-chair of Goodwin Procter’s Life Sciences Practice. He has over 17 years of experience representing biotechnology, pharmaceutical, medical device and medtech companies in all aspects of their business and legal affairs, including VC financings, strategic alliances, M&A and IPOs. Mr. Taft also serves on the firm's Executive Committee. Mr. Taft often serves as outside general counsel to life sciences companies, closely advising management and directors as these companies raise capital, in-license and acquire IP and other assets, and then partner their technology, all with a view towards growth and liquidity. In addition, he regularly advises on licenses, JVs, strategic alliances, collaborations and royalty monetizations.

Education

J.D., 1997 Harvard Law School (magna cum laude) Ph.D., Chemistry, 1993 Massachusetts Institute of Technology B.S., Chemistry, 1989 Yale University (magna cum laude)


United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Goodwin 's Boston-based practice co-head Mitchell Bloom, who specializes in venture capital firms and investment banks focused on life sciences, recently assisted Ablynx with its €3.9bn agreement to be acquired by Sanofi, and advised California-based biopharmaceutical company Eidos on its $106m initial public offering. Co-head Kingsley Taft (also based in Boston) advised long-standing client Moderna on a $500m equity financing round. Surface Oncology and Zagfen are other notable clients. New-York-based Elizabeth Holland is well versed in Hatch-Waxman litigation, while Washington DC’s Julie Tibbets, who joined from Alston & Bird LLP in February 2018, focuses on FDA regulatory work. Other key arrivals in 2018 include New York-based Jonathan Schur and Kristopher Brown from Dechert LLP, San Francisco’s IP litigator Darryl Woo from Vinson & Elkins LLP and Silicon Valley’s Shane Albright from DLA Piper LLP (US). Boston’s Chad Davis moved to  Dechert LLP.

[back to top]

United States: Intellectual property

Patents: licensing

Within: Patents: licensing

Goodwin primarily acts for technology and life sciences clients, both domestic and international. Due diligence in the context of mergers and acquisitions, financings and public offerings are as much part of the team's experience as stand-alone technology transactions, including strategic alliances and collaboration agreements. A recent standout instruction saw Stephen Charkoudian, who jointly heads the practice in Boston with Kingsley Taft, advise Kind on its strategic partnership with Mars. Former DLA Piper LLP (US) practitioner Shane Albright joined in Silicon Valley, while Jonathan Schur joined the New York team from Dechert LLP. Noelle Dubiansky in Washington DC and Bethany Withers in Boston made partner. Other clients include Aerpio Pharmaceuticals, Crispr Therapeutics and WiTricity.

[back to top]

United States: M&A/corporate and commercial

Venture capital and emerging companies

Within: Venture capital and emerging companies

With offices in Boston, Washington DC, New York, Los Angeles and the Bay Area, Goodwin has a wide-ranging, bicoastal practice, which has an excellent reputation for its strength in the life sciences sector; tech is a supplementary area of expertise. The team represented online pharmacy PillPack in its high-profile acquisition by Amazon, and assisted Kensho Technologies with its $550m sale to S&P Global. It also advised Slack Technologies on its $427m Series H financing. Mitchell Bloom and Kingsley Taft, both based in Boston, share leadership of the life sciences team, while John Egan, Anthony McCusker in Silicon Valley, and Kenneth Gordon lead the technology practice. Boston-based Bill Schnoor, who advises robotics company Superpedestrian, is another key contact. Jonathan Axelrad has retired.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to